Overview Fundamentals Financials Technicals Corporate Action Shareholding Pattern Peer Comparison News Stock Analysis About Company FAQs

Valiant Laboratories Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: VALIANTLAB Small Cap ISIN: INE0JWS01017
As on 26 February 2025 at 07:46 IST
As on 26 February 2025 at 07:46 IST
90.96
-0.57
(-0.62%)
Over 1 Month
-9.47%
Over 6 Months
-16.33%
Over 1 Year
-48.81%
Over 3 Years
0%

Valiant Laboratories Ltd Summary

Close ₹ 90.96
Open ₹ 92.13
High ₹ 93.09
Low ₹ 90.52
Volume 18,621
Net Turnover (in ₹ Cr) ₹ 0.16
52Wk High ₹ 179.75
52Wk Low ₹ 90.35
52Wk High / Low
90.35
179.75

Valiant Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 395.22
EPS (TTM) -
Book Value (BV) 52.91
Div. Yield -
P/E (TTM) -59.97
Price/Book Value 1.72
Delivery % 77.02 %
Face Value 10

Key Ratios

PE Ratio 1,820
PB Ratio 2.67
EV to Sales 3.27
PEG Ratio -18.36
ROA 0.11
ROE -1.70
Debt-Equity 0.36
Net Profit Margin -1.57
Operating Profit Margin -1.05

Valiant Laboratories Ltd Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue191.74338.77---
Total Expenses192.51300.64---
Profit Before Tax-0.7738.14---
Profit After Tax0.3229---
Operating Profit after Depreciation-0.6938.39---

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets50.0548.12---
Total Non Current Assets117.1462.39---
Total Current Assets225.54150.58---
TOTAL ASSETS342.69212.97---
Total Shareholder's Fund236.86100.49---

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities1.8956.05---
Net Cash used in Investing Activities-143.88-55.17---
Net Cash used in Financing Activities152.45-0.93---

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue191.73338.77293.47183.78-
Total Expenses192.49300.64251.77136.76-
Profit Before Tax-0.7538.1441.7047.02-
Profit After Tax0.342927.5030.59-
Operating Profit after Depreciation-0.6738.3941.7848.81-

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets31.6129.9722.2319.79-
Total Non Current Assets115.4630.8025.0220.42-
Total Current Assets209.27181.96156.8085.89-
TOTAL ASSETS324.73212.76181.81106.31-
Total Shareholder's Fund236.88100.4971.4688.58-

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities48.7822.962.259.11-
Net Cash used in Investing Activities-182.73-21.18-12.24-16.67-
Net Cash used in Financing Activities135.80-1.536.1811.43-

Particulars (in ₹ Cr.) 2024-12 2024-09 2024-06 2024-03 2023-12
Total Revenue35.2321.4818.8830.5940.52
Total Expenses34.6128.2221.2835.1246.83
Profit Before Tax1.62-3.91-0.17-2.57-5.04
Profit After Tax2.35-4.74-0.51-1.24-3.50
Operating Profit after Depreciation2.20-3.380.41-2.03-4.53

Particulars (in ₹ Cr.) 2024-12 2024-09 2024-06 2024-03 2023-12
Total Revenue35.2321.4818.8830.5840.52
Total Expenses34.6028.2221.2835.1246.83
Profit Before Tax0.73-5.33-0.78-2.56-5.04
Profit After Tax1.60-5.98-1.01-1.22-3.50
Operating Profit after Depreciation1.30-4.81-0.23-2.04-4.53

Valiant Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3
S1 89.74
S2 87.94
S3 85.54
Pivot 92.14
R1 93.94
R2 96.34
R3 98.14

Moving Average

20 SMA 98.81
50 SMA 105.67
100 SMA 110.15
200 SMA 121.21

Valiant Laboratories Ltd Corporate Actions

No available data

Valiant Laboratories Ltd Peer Comparison

Company Price Market Cap (in ₹ Cr)
Valiant Laboratories Ltd ₹91.15 ₹396.05
Sun Pharmaceuticals Industries Ltd ₹1,613.65 ₹3,87,168.69
Divis Laboratories Ltd ₹5,725.20 ₹1,51,986.07
Cipla Ltd ₹1,463.25 ₹1,18,174.12
Torrent Pharmaceuticals Ltd ₹3,028.40 ₹1,02,490.21
Mankind Pharma Ltd ₹2,337.05 ₹96,421.67

Valiant Laboratories Ltd News

Valiant Laboratories to hold board meeting

On 7 February 2025

01 Feb 2025, 12:32 pm

Valiant Laboratories to conduct board meeting

On 12 November 2024

08 Nov 2024, 12:22 pm

Valiant Laboratories to conduct board meeting

On 12 August 2024

09 Aug 2024, 03:05 pm

Valiant Laboratories schedules AGM

On 8 August 2024

18 Jul 2024, 04:22 pm

Valiant Laboratories to hold board meeting

On 14 May 2024

07 May 2024, 02:03 pm

Valiant Laboratories Ltd Stock Analysis

  1. Annual revenue for Valiant Laboratories Ltd decreased by 43.40% to ₹191.73 crore in FY 2024 from ₹338.77 crore in FY 2023.
  2. Annual Net Profit for Valiant Laboratories Ltd decreased by 98.83% to ₹0.34 crore in FY 2024 from ₹29 crore in FY 2023.
  3. Promoter Shareholding in Valiant Laboratories Ltd remains unchanged by 0.00% in the most recent quarter, from 74.94% in September 2024 to 74.94% in December 2024.
  4. Valiant Laboratories Ltd delivered a 1-year return of -48.81% compared to the Nifty 50, which provided a return of 1.92% as of the last trading session.
  5. Valiant Laboratories Ltd share price moved down by 0.62% from its previous close of INR ₹91.53. The latest Valiant Laboratories Ltd share price is INR ₹90.96.
  6. Valiant Laboratories Ltd share price today has been at a low of 90.52 and a high of 93.09. Over the past 52 weeks, the Valiant Laboratories Ltd share price has seen a low of 90.35 and a high of 179.75.

FAQ’s

What is the share price of Valiant Laboratories Ltd today?

Valiant Laboratories Ltd share price as on 26 Feb 2025 is ₹ 90.96

What is the Market Cap of Valiant Laboratories Ltd?

The market cap of Valiant Laboratories Ltd stock is ₹395.22 Cr.

What is the PE Ratio of Valiant Laboratories Ltd?

The Price to Earnings (P/E) Ratio of Valiant Laboratories Ltd is 1,820

What is the PB Ratio of Valiant Laboratories Ltd?

The Price to Book (P/B) Ratio of Valiant Laboratories Ltd is 2.67

What is the 52 week high of Valiant Laboratories Ltd Share Price?

The 52 week high of Valiant Laboratories Ltd share price stands at ₹179.75

What is the 52 week low of Valiant Laboratories Ltd Share Price?

The 52 week low of Valiant Laboratories Ltd share price stands at ₹90.35

Get started with us today and
start building your wealth journey